Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-3179| Publication type: | Article in scientific journal |
| Type of review: | Peer review (publication) |
| Title: | Letter to the editor: newer-generation antidepressants and suicide risk in randomized controlled trials : a re-analysis of the FDA database |
| Authors: | Hengartner, Michael Pascal Plöderl, Martin |
| et. al: | No |
| DOI: | 10.1159/000501215 10.21256/zhaw-3179 |
| Published in: | Psychotherapy and Psychosomatics |
| Volume(Issue): | 88 |
| Issue: | 4 |
| Page(s): | 247 |
| Pages to: | 248 |
| Issue Date: | 24-Jun-2019 |
| Publisher / Ed. Institution: | Karger |
| ISSN: | 0033-3190 1423-0348 |
| Language: | English |
| Subject (DDC): | 616.89: Mental disorders, clinical psychology and psychiatry |
| URI: | https://digitalcollection.zhaw.ch/handle/11475/17418 |
| Fulltext version: | Published version |
| License (according to publishing contract): | CC BY-NC-ND 4.0: Attribution - Non commercial - No derivatives 4.0 International |
| Departement: | Applied Psychology |
| Organisational Unit: | Psychological Institute (PI) |
| Appears in collections: | Publikationen Angewandte Psychologie |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Re-analysis FDA suicide data.pdf | Paper | 93.66 kB | Adobe PDF |  View/Open |
Show full item record
Hengartner, M. P., & Plöderl, M. (2019). Letter to the editor: newer-generation antidepressants and suicide risk in randomized controlled trials : a re-analysis of the FDA database. Psychotherapy and Psychosomatics, 88(4), 247–248. https://doi.org/10.1159/000501215
Hengartner, M.P. and Plöderl, M. (2019) ‘Letter to the editor: newer-generation antidepressants and suicide risk in randomized controlled trials : a re-analysis of the FDA database’, Psychotherapy and Psychosomatics, 88(4), pp. 247–248. Available at: https://doi.org/10.1159/000501215.
M. P. Hengartner and M. Plöderl, “Letter to the editor: newer-generation antidepressants and suicide risk in randomized controlled trials : a re-analysis of the FDA database,” Psychotherapy and Psychosomatics, vol. 88, no. 4, pp. 247–248, Jun. 2019, doi: 10.1159/000501215.
HENGARTNER, Michael Pascal und Martin PLÖDERL, 2019. Letter to the editor: newer-generation antidepressants and suicide risk in randomized controlled trials : a re-analysis of the FDA database. Psychotherapy and Psychosomatics. 24 Juni 2019. Bd. 88, Nr. 4, S. 247–248. DOI 10.1159/000501215
Hengartner, Michael Pascal, and Martin Plöderl. 2019. “Letter to the Editor: Newer-Generation Antidepressants and Suicide Risk in Randomized Controlled Trials : A Re-Analysis of the FDA Database.” Psychotherapy and Psychosomatics 88 (4): 247–48. https://doi.org/10.1159/000501215.
Hengartner, Michael Pascal, and Martin Plöderl. “Letter to the Editor: Newer-Generation Antidepressants and Suicide Risk in Randomized Controlled Trials : A Re-Analysis of the FDA Database.” Psychotherapy and Psychosomatics, vol. 88, no. 4, June 2019, pp. 247–48, https://doi.org/10.1159/000501215.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.